The Relationship Between the Pan-Immune–Inflammation Value (PIV) and Mortality in Elderly Critically Ill Patients with Sepsis: A Single-Centre Retrospective Study
Zusammenhang zwischen dem Pan-Immune-Inflammation Value (PIV) und der Mortalität bei älteren kritisch kranken Patient:innen mit Sepsis: eine monozentrische retrospektive Studie
Journal of Clinical Medicine · 14.05.2026 · 15 (10) · 3801
DOI: 10.3390/jcm15103801 ↗Auf einen Blick
Bei 96 Patient:innen ab 65 Jahren mit Sepsis auf der Intensivstation war der PIV kein signifikanter Prädiktor der 28-Tage-Mortalität. Die Gesamtmortalität betrug 55,2 %.
Fragestellung
Besteht bei älteren kritisch kranken Patient:innen mit Sepsis ein Zusammenhang zwischen PIV und 28-Tage-Mortalität?
Methode
Monozentrische retrospektive Studie bei 96 Patient:innen ab 65 Jahren auf der ICU mit Sepsis nach Sepsis-3; Vergleich von niedriger vs. hoher PIV-Gruppe, Cox- und Kaplan-Meier-Analysen.
Ergebnisse
28-Tage-Mortalität 55,2 % (n = 53). PIV nicht prädiktiv für 28-Tage-Mortalität (AUC 0,550; p = 0,400). Kein Unterschied im Überleben zwischen niedriger und hoher PIV-Gruppe (log-rank p = 0,662).
Schlussfolgerung der Autor:innen
Der PIV kann die 28-Tage-Mortalität bei älteren kritisch kranken Patient:innen mit Sepsis nicht vorhersagen.
Kernaussagen
- 28-Tage-Mortalität insgesamt 55,2 %
- PIV: AUC 0,550; p = 0,400
- Kein Überlebensunterschied zwischen niedriger und hoher PIV-Gruppe
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.05.2026. Verfasst von Yeşim Şerife Bayraktar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Intensive Care, Department of Anesthesiology and Reanimation, Faculty of Medicine, Selcuk University, Konya 42130, Turkey. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Selcuk University Scientific Research Projects Coordination Unit.
Themen: Sepsis
Abstract (Originalsprache)
Background
The pan-immune–inflammation (PIV) score is a hematological index derived from neutrophil, platelet, monocyte and lymphocyte counts. It has been demonstrated that it has high prognostic value in oncological patients. The aim of this study was to evaluate the association between PIV and 28-day mortality in elderly (≥65 years) critically ill patients admitted to the intensive care unit (ICU) with a diagnosis of sepsis.
Methods
This single-centre retrospective study included 96 patients aged ≥65 years who were admitted to the ICU with a diagnosis of sepsis according to the Sepsis-3 criteria between 15 July 2024 and 15 July 2025. Patients were divided into low- and high-PIV groups based on the median PIV. Cox proportional hazards regression analysis and Kaplan–Meier survival analysis were performed.
Results
The overall 28-day mortality rate was found to be 55.2% (n = 53). The median PIV was 866.58 (IQR: 497.34–1978.43). The PIV was shown not to be a significant predictor of 28-day mortality (AUC: 0.550; p = 0.400). No difference in survival was observed between the low- and high-PIV groups in the Kaplan–Meier analysis (log-rank p = 0.662). In multivariate Cox regression, high creatinine (HR: 2.683; p < 0.001), high calcium (HR: 2.312; p = 0.004), a low partial thromboplastin time (HR: 0.396; p = 0.005) and a requirement for vasopressors (HR: 2.225; p = 0.025) were identified as independent predictors of mortality. In the Kaplan–Meier analysis for 28-day survival, chronic obstructive pulmonary disease (p = 0.023) and chronic renal disease (p = 0.034) were found to be significantly associated with poorer survival.
Conclusions
The PIV is unable to predict 28-day mortality in elderly critically ill patients diagnosed with sepsis. This finding suggests that immunosenescence and inflammaging reduce the predictive power of composite hematological indices. Markers of organ dysfunction, coagulopathy and hemodynamic instability remain more reliable prognostic indicators in geriatric patients with sepsis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Intensive Care, Department of Anesthesiology and Reanimation, Faculty of Medicine, Selcuk University, Konya 42130, Turkey.
- Division of Intensive Care, Department of Emergency Medicine, Faculty of Medicine, Selcuk University, Konya 42130, Turkey.
- Division of Intensive Care, Department of Anesthesiology and Reanimation, Beyhekim Training and Research Hospital, Konya 42060, Turkey.
ORCID-Profile: Yeşim Şerife Bayraktar, Yasemin Cebeci, Jale Bengi Çelik
Förderung
- Selcuk University Scientific Research Projects Coordination Unit
Zitieren
APA
Bayraktar, Y. Ş., Uyar, H. G., Cebeci, Y., Özkaya, H., & Çelik, J. B. (2026). The Relationship Between the Pan-Immune–Inflammation Value (PIV) and Mortality in Elderly Critically Ill Patients with Sepsis: A Single-Centre Retrospective Study. Journal of Clinical Medicine, 15(10), 3801. https://doi.org/10.3390/jcm15103801
Vancouver
Bayraktar YŞ, Uyar HG, Cebeci Y, Özkaya H, Çelik JB. The Relationship Between the Pan-Immune–Inflammation Value (PIV) and Mortality in Elderly Critically Ill Patients with Sepsis: A Single-Centre Retrospective Study. Journal of Clinical Medicine. 2026;15(10):3801. doi:10.3390/jcm15103801
BibTeX
@article{Bayraktar2026,
author = {Bayraktar, Yeşim Şerife and Uyar, Hasan Gazi and Cebeci, Yasemin and Özkaya, Hasan and Çelik, Jale Bengi},
title = {The Relationship Between the Pan-Immune–Inflammation Value (PIV) and Mortality in Elderly Critically Ill Patients with Sepsis: A Single-Centre Retrospective Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {10},
pages = {3801},
doi = {10.3390/jcm15103801}
}
EUVIMED